Following the rapid economic development and the severe environmental deterioration during the past three decades, human cancer risk has been increasing rapidly in China. Cancer now is the number one killer in China and the costs for cancer treatment in 2006 reached more than 20% of the annual total medical costs in China, and this number is actually considered to be seriously underestimated. Facing the grave consequence of the ever increasing cancer burden in China;realizing that nationwide deterioration in environmental conditions and human health could jeopardize the economic development, the Chinese government has taken major steps to prevent and control cancer. China, however, faces many challenges in confronting and battling the war against cancer. One of the major shortcomings for cancer prevention and control in China today is the severe lack of well-trained personnel in all major areas of cancer studies. The primary goal of this application is to secure the resources necessary to build a center of excellence in research and teaching in cancer studies within the Cancer Institute, Chinese Academy of Medical Sciences (CI-CAMS, the designated China National Cancer Center), which is mandated by the central government to be responsible for China's cancer prevention and control. The resources will be used to (1) train scientists urgently needed in the CI-CAMS to develop appropriate strategies to better understand and more effectively respond to the emerging threat from the increasing cancer burden in China;(2) build an infrastructure that will allow CI-CAMS to function as a national center for teaching and research in cancer-related studies;and (3) strengthen China's National Cancer Registration Office to function as a national center of excellence for coordinating and monitoring China's cancer registration. The training goals will be achieved through trainees, selected from faculty and existing pre/post-doctoral programs at CI-CAMS, who will receive education and mentoring at Yale School of Public Health (YSPH) through long-term/intermediate/short-term training or workshops and internet-based tutorial system. The training will emphasize principles and methods in major areas of cancer epidemiology and biostatistics. This training program will be administered by a Program Faculty with representation from both CI-CAMS and Yale University. Yale University, YSPH in particular, has a strong history of prior research and training collaborations with China. We anticipate that trainees of this program will be uniquely qualified to be future leaders in the field of cancer research in China.

Public Health Relevance

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Training Grants (D43)
Project #
5D43TW008323-05
Application #
8527869
Study Section
Special Emphasis Panel (ZRG1-BDA-L (50))
Program Officer
Michels, Kathleen M
Project Start
2009-08-08
Project End
2014-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
5
Fiscal Year
2013
Total Cost
$209,367
Indirect Cost
$12,511
Name
Yale University
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Guo, Huan; Jin, Yinlong; Cheng, Yibin et al. (2014) Prenatal exposure to organochlorine pesticides and infant birth weight in China. Chemosphere 110:1-7
Zhu, Cairong; Bassig, Bryan A; Shi, Kunchong et al. (2014) Different time trends by gender for the incidence of Hodgkin's lymphoma among young adults in the USA: a birth cohort phenomenon. Cancer Causes Control 25:923-31
Guo, Huan; Bassig, Bryan A; Lan, Qing et al. (2014) Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 25:1261-70
Chen, Yingtai; Lan, Qing; Zheng, Tongzhang et al. (2013) Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma. Leuk Res 37:1120-4
Chen, Yingtai; Zheng, Tongzhang; Lan, Qing et al. (2013) Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Am J Hematol 88:606-11
Kim, Christopher; Bi, Xiaofeng; Pan, Dongsheng et al. (2013) The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23:575-82
Deng, Qian; Zheng, Tongzhang; Lan, Qing et al. (2013) Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma. Eur J Cancer Prev 22:77-82
Li, Qian; Lan, Qing; Zhang, Yawei et al. (2013) Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma. Cancer Causes Control 24:1875-84
Chen, Qiong; Zheng, Tongzhang; Lan, Qing et al. (2013) Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 22:1332-5
Li, Qian; Chang, Ellen T; Bassig, Bryan A et al. (2013) Body size and risk of Hodgkin's lymphoma by age and gender: a population-based case-control study in Connecticut and Massachusetts. Cancer Causes Control 24:287-95

Showing the most recent 10 out of 30 publications